Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials

Review of hypo-fractionated radiotherapy for localized muscle invasive bladder cancer

(2019) Frédéric Amestoy et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy ± Chemotherapy in the BC2001 Phase III Randomised Controlled Trial

(2019) Robert A. Huddart et al.   EUROPEAN UROLOGY

Dose-limiting Urinary Toxicity With Pembrolizumab Combined With Weekly Hypofractionated Radiation Therapy in Bladder Cancer

(2018) Alison Claire Tree et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies

(2018) C. M. van Leeuwen et al.   Radiation Oncology

Performance of models for estimating absolute risk difference in multicenter trials with binary outcome

(2016) Claudia Pedroza et al.   BMC Medical Research Methodology

2507 Prognostic factors in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004)

(2015) R. Huddart et al.   EUROPEAN JOURNAL OF CANCER

Systematic review of methods for individual patient data meta- analysis with binary outcomes

(2014) Doneal Thomas et al.   BMC Medical Research Methodology

Curative Therapy for Bladder Cancer in Routine Clinical Practice: A Population-based Outcomes Study

(2014) C.M. Booth et al.   CLINICAL ONCOLOGY

Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233

(2014) Raymond H. Mak et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Noninferiority Trial of Reduced High-Dose Volume Versus Standard Volume Radiation Therapy for Muscle-Invasive Bladder Cancer: Results of the BC2001 Trial (CRUK/01/004)

(2013) Robert A. Huddart et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Individual participant data meta-analyses should not ignore clustering

(2013) Ghada Abo-Zaid et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer

(2012) Nicholas D. James et al.   NEW ENGLAND JOURNAL OF MEDICINE

Statistical Analysis of Individual Participant Data Meta-Analyses: A Comparison of Methods and Recommendations for Practice

(2012) Gavin B. Stewart et al.   PLoS One

Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience

(2011) Jason A. Efstathiou et al.   EUROPEAN UROLOGY

Phase II Study of Conformal Hypofractionated Radiotherapy With Concurrent Gemcitabine in Muscle-Invasive Bladder Cancer

(2011) Ananya Choudhury et al.   JOURNAL OF CLINICAL ONCOLOGY

Radiotherapy With Concurrent Carbogen and Nicotinamide in Bladder Carcinoma

(2010) Peter J. Hoskin et al.   JOURNAL OF CLINICAL ONCOLOGY